BRIEF-Biosig Technologies Entered Into At Market Offering Agreement Relating To Sale Of Common Shares Offered By Prospectus Supplement

Reuters

2024-12-19

BRIEF-Biosig Technologies Entered Into At Market Offering Agreement Relating To Sale Of Common Shares Offered By Prospectus Supplement

Dec 18 (Reuters) - BioSig Technologies Inc BSGM.O:

BIOSIG TECHNOLOGIES : ENTERED INTO AT MARKET OFFERING AGREEMENT RELATING TO SALE OF COMMON SHARES OFFERED BY PROSPECTUS SUPPLEMENT
BIOSIG TECHNOLOGIES : MAY FROM TIME TO TIME OFFER AND SELL SHARES OF COMMON STOCK OF UP TO $8.5 MILLION

Source text: [ID:n0001493152-24-050600]

Further company coverage: BSGM.O

((Reuters.Briefs@thomsonreuters.com;))

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2492157365"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2492157365\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2492157365?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-12-19 05:44","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2492157365","market":"us","top_or_hot":-1,"title":"BRIEF-Biosig Technologies  Entered Into At Market Offering Agreement Relating To Sale Of Common Shares Offered By Prospectus Supplement","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Biosig Technologies  Entered Into At Market Offering Agreement Relating To Sale Of Common Shares Offered By Prospectus Supplement</title></head><body><p><span>Dec 18 (Reuters)</span><span> - </span>BioSig Technologies Inc <span>BSGM.O</span>:</p><ul><li><p>BIOSIG TECHNOLOGIES : ENTERED INTO AT MARKET OFFERING AGREEMENT RELATING TO SALE OF COMMON SHARES OFFERED BY PROSPECTUS SUPPLEMENT</p></li><li><p>BIOSIG TECHNOLOGIES : MAY FROM TIME TO TIME OFFER AND SELL SHARES OF COMMON STOCK OF UP TO $8.5 MILLION</p></li></ul><p>Source text: [ID:n0001493152-24-050600]</p><p>Further company coverage: <span>BSGM.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Biosig Technologies  Entered Into At Market Offering Agreement Relating To Sale Of Common Shares Offered By Prospectus Supplement</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Biosig Technologies  Entered Into At Market Offering Agreement Relating To Sale Of Common Shares Offered By Prospectus Supplement\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2024-12-19 05:44</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Biosig Technologies  Entered Into At Market Offering Agreement Relating To Sale Of Common Shares Offered By Prospectus Supplement</title></head><body><p><span>Dec 18 (Reuters)</span><span> - </span>BioSig Technologies Inc <span>BSGM.O</span>:</p><ul><li><p>BIOSIG TECHNOLOGIES : ENTERED INTO AT MARKET OFFERING AGREEMENT RELATING TO SALE OF COMMON SHARES OFFERED BY PROSPECTUS SUPPLEMENT</p></li><li><p>BIOSIG TECHNOLOGIES : MAY FROM TIME TO TIME OFFER AND SELL SHARES OF COMMON STOCK OF UP TO $8.5 MILLION</p></li></ul><p>Source text: [ID:n0001493152-24-050600]</p><p>Further company coverage: <span>BSGM.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4082","symbol_name":"医疗保健设备","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241218:nFWN3NJ0IU:1","article_id":"2492157365","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2492157365","pubTimestamp":1734558272,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-Biosig Technologies  Entered Into At Market Offering Agreement Relating To Sale Of Common Shares Offered By Prospectus SupplementDec 18  - BioSig Technologies Inc BSGM.O:BIOSIG TECHNOLOGIES : ENTERED INTO AT MARKET OFFERING AGREEMENT RELATING TO SALE OF COMMON SHARES OFFERED BY PROSPECTUS SUPPLEMENTBIOSIG TECHNOLOGIES : MAY FROM TIME TO TIME OFFER AND SELL SHARES OF COMMON STOCK OF UP TO $8.5 MILLIONSource text: [ID:n0001493152-24-050600]Further company coverage: BSGM.O ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4082":"医疗保健设备","BSGM":"BioSig Technologies, Inc."},"translate_title":"简介-Biosig Technologies签订了有关出售招股说明书补充文件中提供的普通股的市场发行协议","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BSGM":0.9},"content_text":"BRIEF-Biosig Technologies  Entered Into At Market Offering Agreement Relating To Sale Of Common Shares Offered By Prospectus SupplementDec 18 (Reuters) - BioSig Technologies Inc BSGM.O:BIOSIG TECHNOLOGIES : ENTERED INTO AT MARKET OFFERING AGREEMENT RELATING TO SALE OF COMMON SHARES OFFERED BY PROSPECTUS SUPPLEMENTBIOSIG TECHNOLOGIES : MAY FROM TIME TO TIME OFFER AND SELL SHARES OF COMMON STOCK OF UP TO $8.5 MILLIONSource text: [ID:n0001493152-24-050600]Further company coverage: BSGM.O ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":1}}}